Gilbert & Cook’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.34M Buy
1,454
+4
+0.3% +$4.05K 0.17% 47
2025
Q4
$1.56M Sell
1,450
-315
-18% -$301K 0.2% 46
2025
Q3
$1.35M Sell
1,765
-6
-0.3% -$4.46K 0.17% 59
2025
Q2
$1.38M Sell
1,771
-12
-0.7% -$9.32K 0.19% 48
2025
Q1
$1.47M Buy
1,783
+40
+2% +$33.3K 0.21% 42
2024
Q4
$1.35M Hold
1,743
0.19% 46
2024
Q3
$1.54M Sell
1,743
-14
-0.8% -$12.6K 0.21% 37
2024
Q2
$1.59M Hold
1,757
0.23% 32
2024
Q1
$1.37M Buy
1,757
+9
+0.5% +$6.41K 0.19% 52
2023
Q4
$1.02M Sell
1,748
-81
-4% -$47.3K 0.14% 65
2023
Q3
$982K Sell
1,829
-1,474
-45% -$760K 0.15% 55
2023
Q2
$1.55M Sell
3,303
-453
-12% -$190K 0.25% 30
2023
Q1
$1.29M Sell
3,756
-549
-13% -$185K 0.22% 33
2022
Q4
$1.57M Sell
4,305
-146
-3% -$51.8K 0.29% 27
2022
Q3
$1.58M Buy
4,451
+256
+6% +$81.1K 0.35% 27
2022
Q2
$1.36M Sell
4,195
-767
-15% -$230K 0.24% 32
2022
Q1
$1.42M Buy
4,962
+525
+12% +$135K 0.23% 31
2021
Q4
$1.23M Buy
4,437
+608
+16% +$154K 0.2% 35
2021
Q3
$885K Buy
3,829
+1,230
+47% +$304K 0.16% 53
2021
Q2
$597K Sell
2,599
-1,810
-41% -$364K 0.11% 81
2021
Q1
$824K Buy
4,409
+332
+8% +$64.9K 0.16% 51
2020
Q4
$687K Buy
4,077
+1,321
+48% +$197K 0.15% 53
2020
Q3
$408K Buy
2,756
+113
+4% +$17.5K 0.1% 77
2020
Q2
$434K Buy
2,643
+838
+46% +$129K 0.11% 69
2020
Q1
$250K Buy
1,805
+55
+3% +$7.56K 0.07% 93
2019
Q4
$230K Buy
+1,750
New +$203K 0.06% 134
2019
Q2
Sell
-1,669
Closed -$216K 118
2019
Q1
$216K Buy
+1,669
New +$203K 0.07% 100

Other funds holding LLY

Gilbert & Cook's LLY Position: Q1 2026 in Review

Gilbert & Cook increased its Eli Lilly (LLY) stake by 0.28% in Q1 2026, buying an estimated $4.05K and bringing the position to 1,454 shares worth $1.34M. The position accounts for 0.17% of the portfolio, ranked #47.

Gilbert & Cook first reported a position in LLY in Q1 2019 and has held it in 27 quarters since. The position peaked at $1.59M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Gilbert & Cook held 1,454 shares of Eli Lilly worth $1.34M as of Q1 2026.
  • Gilbert & Cook bought 4 Eli Lilly shares in Q1 2026, an estimated $4.05K.
  • Eli Lilly made up 0.17% of Gilbert & Cook's portfolio in Q1 2026, its #47 holding.
  • Gilbert & Cook first reported a position in Eli Lilly in Q1 2019 and has held it in 27 quarters since.
  • Gilbert & Cook's Eli Lilly position peaked at $1.59M in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Gilbert & Cook's 13F filing for Q1 2026, filed 5 May 2026.